$269 Million is the total value of Tri Locum Partners LP's 59 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 67.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AVDL | Sell | AVADEL PHARMACEUTICALS PLCsponsored adr | $17,130,532 | +40.9% | 1,039,474 | -21.7% | 6.37% | +72.0% |
| WST | Sell | WEST PHARMACEUTICAL SVSC INC | $15,512,218 | -33.0% | 40,558 | -39.3% | 5.76% | -18.3% |
| REGN | Sell | REGENERON PHARMACEUTICALS | $14,833,540 | -58.4% | 20,644 | -52.4% | 5.51% | -49.2% |
| CTLT | Sell | CATALENT INC | $8,715,230 | -41.2% | 200,997 | -10.8% | 3.24% | -28.2% |
| ILMN | Sell | ILLUMINA INC | $7,655,592 | -47.6% | 40,832 | -35.0% | 2.84% | -36.1% |
| Sell | STEVANATO GROUP S P A | $5,710,504 | -20.5% | 176,359 | -36.4% | 2.12% | -3.1% | |
| Sell | ROIVANT SCIENCES LTD | $2,040,252 | -19.8% | 202,406 | -41.3% | 0.76% | -2.1% | |
| Sell | VENTYX BIOSCIENCES INC | $1,895,840 | -63.0% | 57,800 | -62.2% | 0.70% | -54.8% | |
| Sell | ASTRIA THERAPEUTICS INC | $1,866,536 | -49.0% | 224,074 | -18.5% | 0.69% | -37.7% | |
| XENE | Sell | XENON PHARMACEUTICALS INC | $932,509 | -88.2% | 24,221 | -89.1% | 0.35% | -85.6% |
| PTGX | Sell | PROTAGONIST THERAPEUTICS INC | $932,175 | -69.6% | 33,750 | -74.7% | 0.35% | -63.0% |
| FEMY | Sell | FEMASYS INC | $56,970 | -58.5% | 111,706 | -11.7% | 0.02% | -50.0% |
| UNIT | Exit | UNITI GROUP INC | $0 | – | -11,370 | -100.0% | -0.01% | – |
| SWN | Exit | SOUTHWESTERN ENERGY CO | $0 | – | -10,357 | -100.0% | -0.02% | – |
| ETRN | Exit | EQUITRANS MIDSTREAM CORP | $0 | – | -10,131 | -100.0% | -0.02% | – |
| PGRE | Exit | PARAMOUNT GROUP INC | $0 | – | -15,008 | -100.0% | -0.02% | – |
| BTG | Exit | B2GOLD CORP | $0 | – | -19,076 | -100.0% | -0.02% | – |
| EOLS | Exit | EVOLUS INC | $0 | – | -160,269 | -100.0% | -0.41% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -528,814 | -100.0% | -0.68% | – |
| ISEE | Exit | IVERIC BIO INC | $0 | – | -106,711 | -100.0% | -0.79% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -28,470 | -100.0% | -0.93% | – |
| BEAM | Exit | BEAM THERAPEUTICS INC | $0 | – | -107,230 | -100.0% | -1.00% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -1.01% | – |
| AKRO | Exit | AKERO THERAPEUTICS INC | $0 | – | -88,524 | -100.0% | -1.03% | – |
| INSP | Exit | INSPIRE MED SYS INC | $0 | – | -17,523 | -100.0% | -1.25% | – |
| QURE | Exit | UNIQURE NV | $0 | – | -227,273 | -100.0% | -1.39% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -77,048 | -100.0% | -1.55% | – |
| GH | Exit | GUARDANT HEALTH INC | $0 | – | -255,011 | -100.0% | -1.82% | – |
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INC | $0 | – | -76,070 | -100.0% | -2.25% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -49,213 | -100.0% | -2.39% | – |
| EVH | Exit | EVOLENT HEALTH INCcl a | $0 | – | -268,011 | -100.0% | -2.65% | – |
| TMO | Exit | THERMO FISHER SCIENTIFIC INC | $0 | – | -15,889 | -100.0% | -2.79% | – |
| MRK | Exit | MERCK & CO INC | $0 | – | -114,242 | -100.0% | -3.70% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -88,961 | -100.0% | -3.73% | – |
| ARKK | Exit | ARK ETF TRunit | $0 | – | -350,000 | -100.0% | -4.30% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -417,448 | -100.0% | -5.16% | – |
| ABT | Exit | ABBOTT LABS | $0 | – | -174,802 | -100.0% | -5.39% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FEMASYS INC | 13 | Q2 2024 | 0.5% |
| REGENERON PHARMACEUTICALS | 12 | Q2 2024 | 13.8% |
| XENON PHARMACEUTICALS INC | 11 | Q2 2024 | 4.7% |
| ARGENX SE | 10 | Q2 2024 | 12.8% |
| AVADEL PHARMACEUTICALS PLC | 10 | Q2 2024 | 7.0% |
| LILLY ELI & CO | 9 | Q2 2023 | 9.5% |
| STEVANATO GROUP S P A | 8 | Q2 2024 | 5.8% |
| X4 PHARMACEUTICALS INC | 8 | Q3 2023 | 3.0% |
| TEVA PHARMACEUTICAL INDS LTD | 7 | Q2 2024 | 10.8% |
| AXSOME THERAPEUTICS INC | 7 | Q2 2024 | 6.2% |
View Tri Locum Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-27 |
| 13F-HR | 2023-02-14 |
View Tri Locum Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.